Search for anti-leukemic drugs targeting the cancer-related transcription factor Runx1/CBFbeta
Project/Area Number |
16H03293
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Chemical biology
|
Research Institution | Yokohama City University |
Principal Investigator |
Ogata Kazuhiro 横浜市立大学, 医学研究科, 教授 (90260330)
|
Co-Investigator(Kenkyū-buntansha) |
浜田 恵輔 横浜市立大学, 医学部, 助教 (00344052)
仙石 徹 横浜市立大学, 医学部, 講師 (60576312)
椎名 政昭 横浜市立大学, 医学部, 助教 (30347299)
|
Project Period (FY) |
2016-04-01 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥18,850,000 (Direct Cost: ¥14,500,000、Indirect Cost: ¥4,350,000)
Fiscal Year 2018: ¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2017: ¥6,890,000 (Direct Cost: ¥5,300,000、Indirect Cost: ¥1,590,000)
Fiscal Year 2016: ¥7,540,000 (Direct Cost: ¥5,800,000、Indirect Cost: ¥1,740,000)
|
Keywords | 転写因子 / 転写制御 / がん / 創薬 / 癌 / 医薬品探索 / 分子標的薬 |
Outline of Final Research Achievements |
The molecule targeted therapy has been shown to be effective against various cancers. One of the potential targets is a transcription factor because its mutation is known to be frequently involved in cancer development. However, few drugs targeting transcription factors have been available. We have aimed to develop anti-leukemic drugs targeting a transcription factor, Runx1. Runx1 is a master regulator of the blood cell development, and various mutations of Runx1 gene have frequently been found in acute myelogenous leukemia (AML) patients. We have searched for compounds that could destabilize the regulatory region of Runx1-DNA binding based on the molecular structure, and verified that some compounds have an ability to bind to Runx1 and inhibit DNA binding of Runx1. Furthermore, we have shown that these compounds could inhibit the transcriptional activation ability of Runx1 and decrease the cell-survival rate for the Kasumi-1 AML cells with the Runx1 mutation.
|
Academic Significance and Societal Importance of the Research Achievements |
変異型の転写因子は、ドミナント・ネガティブな様式で転写制御異常を誘起し、細胞の分化異常やがん化の原因となり得る。そのため、変異分子を含んだ異常な複合体の形成要因となる分子間相互作用を標的とした阻害薬は有望な治療薬候補となる。我々は急性骨髄性白血病の発症に関わる主要な転写因子の一つであるRunx1のDNA結合活性における制御部位を分子構造解析と機能解析の結果から明らかにし、その領域を介してアロステリックな様式で作用し得るDNA結合阻害薬を複数見出した。今後、これら阻害薬の構造の最適化を目指す。これまでに転写因子を標的とした阻害薬の報告例は極めて少ないため、大きな波及効果を生むことを期待している。
|
Report
(4 results)
Research Products
(34 results)
-
-
-
[Journal Article] De novo hotspot variants in CYFIP2 cause early-onset epileptic encephalopathy2018
Author(s)
Nakashima Mitsuko、Kato Mitsuhiro、Aoto Kazushi、Shiina Masaaki、Belal Hazrat、Mukaida Souichi、Kumada Satoko、Sato Atsushi、Zerem Ayelet、Lerman-Sagie Tally、Lev Dorit、Leong Huey Yin、Tsurusaki Yoshinori、Mizuguchi Takeshi、Miyatake Satoko、Miyake Noriko、Ogata Kazuhiro、Saitsu Hirotomo、Matsumoto Naomichi
-
Journal Title
Annals of Neurology
Volume: 83
Issue: 4
Pages: 794-806
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
[Journal Article] A homozygous NOP14 variant is likely to cause recurrent pregnancy loss2018
Author(s)
Suzuki Toshifumi、Behnam Mahdiyeh、Ronasian Firooze、Salehi Mansoor、Shiina Masaaki、Koshimizu Eriko、Fujita Atsushi、Sekiguchi Futoshi、Miyatake Satoko、Mizuguchi Takeshi、Nakashima Mitsuko、Ogata Kazuhiro、Takeda Satoru、Matsumoto Naomichi、Miyake Noriko
-
Journal Title
Journal of Human Genetics
Volume: 63
Issue: 4
Pages: 425-430
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
[Journal Article] Heterozygous Mutations in OAS1 Cause Infantile-Onset Pulmonary Alveolar Proteinosis with Hypogammaglobulinemia.2018
Author(s)
Cho K, Yamada M, Agematsu K, Kanegane H, Miyake N, Ueki M, Akimoto T, Kobayashi N, Ikemoto S, Tanino M, Fujita A, Hayasaka I, Miyamoto S, Tanaka-Kubota M, Nakata K, Shiina M, Ogata K, Minakami H, Matsumoto N, Ariga T.
-
Journal Title
Am J Hum Genet
Volume: 102
Issue: 3
Pages: 480-486
DOI
NAID
Related Report
Peer Reviewed / Open Access
-
[Journal Article] De novo variants in CAMK2A and CAMK2B cause neurodevelopmental disorders2018
Author(s)
Akita Tenpei、Aoto Kazushi、Kato Mitsuhiro、Shiina Masaaki、Mutoh Hiroki、Nakashima Mitsuko、Kuki Ichiro、Okazaki Shin、Magara Shinichi、Shiihara Takashi、Yokochi Kenji、Aiba Kaori、Tohyama Jun、Ohba Chihiro、Miyatake Satoko、Miyake Noriko、Ogata Kazuhiro、Fukuda Atsuo、Matsumoto Naomichi、Saitsu Hirotomo
-
Journal Title
Annals of Clinical and Translational Neurology
Volume: 5
Issue: 3
Pages: 280-296
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
[Journal Article] GRIN2D variants in three cases of developmental and epileptic encephalopathy2018
Author(s)
Tsuchida Naomi、Hamada Keisuke、Shiina Masaaki、Kato Mitsuhiro、Kobayashi Yu、Tohyama Jun、Kimura Kazue、Hoshino Kyoko、Ganesan Vigneswari、Teik Keng W.、Nakashima Mitsuko、Mitsuhashi Satomi、Mizuguchi Takeshi、Takata Atsushi、Miyake Noriko、Saitsu Hirotomo、Ogata Kazuhiro、Miyatake Satoko、Matsumoto Naomichi
-
Journal Title
Clinical Genetics
Volume: 94
Issue: 6
Pages: 538-547
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
-
-
[Journal Article] A novel GFI1B mutation at the first zinc finger domain causes congenital macrothrombocytopenia2017
Author(s)
Uchiyama Y, Ogawa Y, Kunishima S, Shiina M, Nakashima M, Yanagisawa K, Yokohama A, Imagawa E, Miyatake S, Mizuguchi T, Takata A, Miyake N, Ogata K, Handa H, Matsumoto N
-
Journal Title
British Journal of Haematology
Volume: 印刷中
Issue: 6
Pages: 843-847
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
[Journal Article] A novel missense mutation affecting the same amino acid as the recurrent PACS1 mutation in Schuurs-Hoeijmakers syndrome2017
Author(s)
Miyake N, Ozasa S, Mabe H, Kimura S, Shiina M, Imagawa E, Miyatake S, Nakashima M, Mizuguchi T, Takata A, Ogata K, Matsumoto N
-
Journal Title
Clinical Genetics
Volume: 93
Issue: 4
Pages: 929-930
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
-
[Journal Article] Biallelic mutations in MYPN, encoding Myopalladin, are associated with childhood-onset, slowly progressive nemaline myopathy2017
Author(s)
Miyatake S, Mitsuhashi S, Hayashi YK, Purevjav E, Nishikawa A, Koshimizu E, Suzuki M, Yatabe K, Tanaka Y, Ogata K, Kuru S, Shiina M, Tsurusaki Y, Nakashima M, Mizuguchi T, Miyake N, Saitsu H, Ogata K, Kawai M, Towbin J, Nonaka I, Nishino I, Matsumoto N
-
Journal Title
American Journal of Human Genetics
Volume: 100
Issue: 1
Pages: 169-178
DOI
Related Report
Peer Reviewed / Int'l Joint Research / Acknowledgement Compliant
-
[Journal Article] The first report of Japanese patients with asparagine synthetase deficiency2017
Author(s)
Yamamoto T, Endo W, Ohnishi H, Kubota K, Kawamoto N, Inui T, Imamura A, Takanashi JI, Shiina M, Saitsu H, Ogata K, Matsumoto N, Haginoya K, Fukao T
-
Journal Title
Brain Development
Volume: 39
Issue: 3
Pages: 236-242
DOI
Related Report
Peer Reviewed
-
[Journal Article] PARS2 and NARS2 mutations in infantile-onset neurodegenerative disorder2017
Author(s)
Mizuguchi T, Nakashima M, Kato M, Yamada K, Okanishi T, Ekhilevitch N, Mandel H, Eran A, Toyono M, Sawaishi Y, Motoi H, Shiina M, Ogata K, Miyatake S, Miyake N, Saitsu H, Matsumoto N
-
Journal Title
Journal of Human Genetics
Volume: 62
Issue: 5
Pages: 525-529
DOI
NAID
Related Report
Peer Reviewed / Int'l Joint Research / Acknowledgement Compliant
-
-
[Journal Article] Biallelic mutations in the 3' exonuclease TOE1 cause pontocerebellar hypoplasia and uncover a role in snRNA processing2017
Author(s)
Lardelli RM, Schaffer AE, Eggens VR, ... Matsumoto N, Muramatsu K, Saitsu H, Shiina M, Ogata K, Foulds N, Dobyns WB, Chi NC, Traver D, Spaccini L, Bova SM, Gabriel SB, Gunel M, Valente EM, Nassogne MC, Bennett EJ, Yeo GW, Baas F, Lykke-Andersen J, Gleeson JG
-
Journal Title
Nature Genetics
Volume: 49
Issue: 3
Pages: 457-464
DOI
Related Report
Peer Reviewed / Int'l Joint Research / Acknowledgement Compliant
-
-
-
[Presentation] Search for anti-leukemic drugs targeting the transcription factor Runx1 by INTENDD2017
Author(s)
Shiina M, Baba S, Uchiyama A, Okada C, Tanaka T, Ikeda K, Kawakita S, Matsuzaki T, Komatsu H, Hosoda M, Ogata K
Organizer
The 137th Annual Meeting of the Pharmaceutical Society of Japan, 3rd International Symposium for Medicinal Sciences
Related Report
Int'l Joint Research / Invited
-
-
-
-
-
[Presentation] Search for anti-leukemic drugs targeting the transcription factor Runx1 by INTENDD.2017
Author(s)
Shiina M, Baba S, Uchiyama A, Okada C, Tanaka T, Ikeda K, Kawakita S, Matsuzaki T, Komatsu H, Hosoda M, Ogata K
Organizer
The 137th Annual Meeting of the Pharmaceutical Society of Japan, 3rd International Symposium for Medicinal Sciences
Related Report
Int'l Joint Research / Invited
-
-
-
-